| Tumor indoleamine 2, 3-dioxygenase (IDO) inhibits CD19-CAR T cells and is downregulated by lymphodepleting drugs S Ninomiya, N Narala, L Huye, S Yagyu, B Savoldo, G Dotti, HE Heslop, ... Blood, The Journal of the American Society of Hematology 125 (25), 3905-3916, 2015 | 324 | 2015 |
| Circulating muscle-specific microRNA, miR-206, as a potential diagnostic marker for rhabdomyosarcoma M Miyachi, K Tsuchiya, H Yoshida, S Yagyu, K Kikuchi, A Misawa, ... Biochemical and biophysical research communications 400 (1), 89-93, 2010 | 166 | 2010 |
| Restoration of p53 pathway by nutlin-3 induces cell cycle arrest and apoptosis in human rhabdomyosarcoma cells M Miyachi, N Kakazu, S Yagyu, Y Katsumi, S Tsubai-Shimizu, K Kikuchi, ... Clinical Cancer Research 15 (12), 4077-4084, 2009 | 120 | 2009 |
| Effects of PAX3-FKHR on malignant phenotypes in alveolar rhabdomyosarcoma K Kikuchi, K Tsuchiya, O Otabe, T Gotoh, S Tamura, Y Katsumi, S Yagyu, ... Biochemical and biophysical research communications 365 (3), 568-574, 2008 | 110 | 2008 |
| An inducible caspase-9 suicide gene to improve the safety of therapy using human induced pluripotent stem cells S Yagyu, V Hoyos, F Del Bufalo, MK Brenner Molecular Therapy 23 (9), 1475-1485, 2015 | 103 | 2015 |
| Biological characteristics of the leukemia-associated transcriptional factor AML1 disclosed by hematopoietic rescue of AML1-deficient embryonic stem cells by using a knock-in … T Okuda, K Takeda, Y Fujita, M Nishimura, S Yagyu, M Yoshida, S Akira, ... Molecular and Cellular Biology, 2000 | 90 | 2000 |
| 3D modeling of human cancer: A PEG-fibrin hydrogel system to study the role of tumor microenvironment and recapitulate the in vivo effect of oncolytic adenovirus F Del Bufalo, T Manzo, V Hoyos, S Yagyu, I Caruana, J Jacot, ... Biomaterials 84, 76-85, 2016 | 74 | 2016 |
| RASSF1A hypermethylation in pretreatment serum DNA of neuroblastoma patients: a prognostic marker A Misawa, S Tanaka, S Yagyu, K Tsuchiya, T Iehara, T Sugimoto, H Hosoi British journal of cancer 100 (2), 399-404, 2009 | 67 | 2009 |
| Bortezomib sensitizes non-small cell lung cancer to mesenchymal stromal cell-delivered inducible caspase-9-mediated cytotoxicity M Ando, V Hoyos, S Yagyu, W Tao, CA Ramos, G Dotti, MK Brenner, ... Cancer gene therapy 21 (11), 472-482, 2014 | 56 | 2014 |
| Circulating methylated-DCR2 gene in serum as an indicator of prognosis and therapeutic efficacy in patients with MYCN nonamplified neuroblastoma S Yagyu, T Gotoh, T Iehara, M Miyachi, Y Katsumi, S Tsubai-Shimizu, ... Clinical Cancer Research 14 (21), 7011-7019, 2008 | 48 | 2008 |
| Sensitivity of malignant rhabdoid tumor cell lines to PD 0332991 is inversely correlated with p16 expression Y Katsumi, T Iehara, M Miyachi, S Yagyu, S Tsubai-Shimizu, K Kikuchi, ... Biochemical and biophysical research communications 413 (1), 62-68, 2011 | 47 | 2011 |
| Mesenchymal stromal cells for linked delivery of oncolytic and apoptotic adenoviruses to non-small-cell lung cancers V Hoyos, F Del Bufalo, S Yagyu, M Ando, G Dotti, M Suzuki, ... Molecular Therapy 23 (9), 1497-1506, 2015 | 42 | 2015 |
| Serum-Based Quantification of MYCN Gene Amplification in Young Patients with Neuroblastoma: Potential Utility as a Surrogate Biomarker for Neuroblastoma S Yagyu, T Iehara, S Tanaka, T Gotoh, A Misawa-Furihata, T Sugimoto, ... PLoS One 11 (8), e0161039, 2016 | 31 | 2016 |
| Preoperative analysis of 11q loss using circulating tumor-released DNA in serum: a novel diagnostic tool for therapy stratification of neuroblastoma S Yagyu, T Iehara, T Gotoh, M Miyachi, Y Katsumi, K Kikuchi, K Tsuchiya, ... Cancer letters 309 (2), 185-189, 2011 | 28 | 2011 |
| Autologous antigen-presenting cells efficiently expand piggyBac transposon CAR-T cells with predominant memory phenotype K Nakamura, S Yagyu, S Hirota, A Tomida, M Kondo, T Shigeura, ... Molecular Therapy-Methods & Clinical Development 21, 315-324, 2021 | 27 | 2021 |
| PAX3-NCOA2 fusion gene has a dual role in promoting the proliferation and inhibiting the myogenic differentiation of rhabdomyosarcoma cells H Yoshida, M Miyachi, K Sakamoto, K Ouchi, S Yagyu, K Kikuchi, ... Oncogene 33 (49), 5601-5608, 2014 | 27 | 2014 |
| Mutated GM‐CSF‐based CAR‐T cells targeting CD116/CD131 complexes exhibit enhanced anti‐tumor effects against acute myeloid leukaemia A Hasegawa, S Saito, S Narimatsu, S Nakano, M Nagai, H Ohnota, ... Clinical & Translational Immunology 10 (5), e1282, 2021 | 26 | 2021 |
| Development of non-viral, ligand-dependent, EPHB4-specific chimeric antigen receptor T cells for treatment of rhabdomyosarcoma H Kubo, S Yagyu, K Nakamura, K Yamashima, A Tomida, K Kikuchi, ... Molecular Therapy-Oncolytics 20, 646-658, 2021 | 25 | 2021 |
| Combinatorial treatment with oncolytic adenovirus and helper-dependent adenovirus augments adenoviral cancer gene therapy L Farzad, V Cerullo, S Yagyu, T Bertin, A Hemminki, C Rooney, B Lee, ... Molecular Therapy-Oncolytics 1, 2014 | 24 | 2014 |
| Multiple mechanisms determine the sensitivity of human-induced pluripotent stem cells to the inducible caspase-9 safety switch S Yagyu, V Hoyos, F Del Bufalo, MK Brenner Molecular Therapy Methods & Clinical Development 3, 2016 | 20 | 2016 |
